Halozyme Therapeutics (HALO) Receivables - Net (2010 - 2026)
Halozyme Therapeutics (HALO) reported Receivables - Net of $455.83 million for Q2 2026, up 44.1% from $316.34 million a year earlier but down 0.5% from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Receivables - Net (2010 - 2026) Analysis & Trends
At the end of FY2025, Halozyme Therapeutics posted Receivables - Net of $441.27 million, up 43.1% from FY2024.
- Receivables - Net has increased for four consecutive years, with a five-year compound annual growth rate of 35.2% (FY2020 to FY2025).
- By year, Receivables - Net came in at $308.46 million in FY2024 (+31.7%), $234.21 million in FY2023 (+1.4%), $231.07 million in FY2022 (+154.0%) and $90.98 million in FY2021 (-6.9%).
- Five-year quarterly Receivables - Net spans a low of $90.98 million in Q4 2021 and a high of $457.99 million in Q1 2026.
- Year over year, Receivables - Net has now increased in each of the last eight quarters, with growth averaging 40.6% over the last eight quarters.
- The high point for year-over-year Receivables - Net in five years was Q3 2022 (growth of 108.1%); the low point was Q2 2024 (a decline of 12.9%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $457.99 million (Q1 2026), $441.27 million (Q4 2025) and $346.04 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Halozyme Therapeutics | 11.78 Bn | 10.02 Bn | 410.50 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 525.59 Mn |
| Jun 30, 2026 | 455.83 Mn |
| Mar 31, 2026 | 457.99 Mn |
| Dec 31, 2025 | 441.27 Mn |
| Sep 30, 2025 | 346.04 Mn |
| Jun 30, 2025 | 316.34 Mn |
| Mar 31, 2025 | 304.62 Mn |
| Dec 31, 2024 | 308.46 Mn |
| Sep 30, 2024 | 285.74 Mn |
| Jun 30, 2024 | 214.52 Mn |
| Mar 31, 2024 | 195.90 Mn |
| Dec 31, 2023 | 234.21 Mn |
| Sep 30, 2023 | 217.33 Mn |
| Jun 30, 2023 | 246.18 Mn |
| Mar 31, 2023 | 194.88 Mn |
| Dec 31, 2022 | 186.97 Mn |
| Sep 30, 2022 | 233.30 Mn |
| Jun 30, 2022 | 189.37 Mn |
| Mar 31, 2022 | 113.76 Mn |
| Dec 31, 2021 | 90.98 Mn |
API Access
Halozyme Therapeutics Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();